The heterodimer-disruptive point mutations found in the β2 (CD18) and β3 subunits in patients with LAD I and Glanzmann’s thrombasthenia (a bleeding disorder), respectively, map to the βA domain and commonly involve residues at the βA-propeller interface87. The gene discussed is ITGB2; the disease is hemorrhagic disease.